-
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
05 Feb 2025 06:24 GMT
… of extensive-stage small cell lung cancer (ES-SCLC).
MVASI ® … extensive-stage small cell lung cancer (ES-SCLC) with … fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy.
CodeBreaK 301, … -squamous non-small cell lung cancer.
A randomized, double- …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… include doxorubicin, pirarubicin, irinotecan, oxaliplatin, cisplatin, gemcitabine … drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis … assessment of lung cancer resection specimens …
-
Oxyresveratrol Alleviates Irinotecan-Induced Diarrhea and Enhances Antitumor Effects in Colorectal Cancer
27 Dec 2024 08:22 GMT
… Wang from Sichuan University. Irinotecan hydrochloride (CPT-11, … H520 non-small cell lung cancer cells and induce apoptosis … of Oxyresveratrol (OXY) and Irinotecan (CPT-11) holds … cancer cells, which mitigates irinotecan-induced apoptosis. Transl Oncol. …
-
New Therapies Expand Options in Recurrent Small Cell Lung Cancer
14 Nov 2024 00:03 GMT
… to managing recurrent small cell lung cancer (SCLC), especially in patients who … we had were topotecan and irinotecan, but as of May of …
-
New therapies lurbinectedin and tarlatamab bring hope for small cell lung cancer treatment
07 Nov 2024 05:16 GMT
… small cell lung cancer (SCLC), one of the least curable lung cancers, is about … carboplatin arm.
“In small cell lung cancer, atezolizumab showed efficacy independent of … drugs, including topotecan, belotecan, and irinotecan.
“The side effects of lurbinectedin …
-
Current Status and Future Prospects of TROP-2 ADCs in Lung Cancer Treatment
05 Nov 2024 16:00 GMT
… Characteristics of Patients with Lung Cancer
Lung cancer is a complex and … the active metabolite of irinotecan, a topoisomerase I inhibitor … in the treatment of lung cancers, and a clinical … novel therapeutic approach in lung cancer. Lung Cancer. 2022;163:96– …
-
Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea
30 Oct 2024 08:51 GMT
… lung cancer (SCLC) accounts for approximately 10– 15% of all lung cancers … confirmed small cell lung cancer (SCLC) who … line chemotherapy regimens (topotecan, irinotecan + platinum (IP), and … stage small cell lung cancer. Clin Lung Cancer. 2023;24( …
-
Pfizer’s BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial
03 Feb 2025 12:13 GMT
… with cetuximab arm compared to irinotecan with cetuximab or FOLFIRI with … with cetuximab arm compared to irinotecan with cetuximab or FOLFIRI with … , and thoracic cancers, which includes lung cancer. Driven by science, we are …
-
Jazz's almost-withdrawn lung cancer drug Zepzelca extends life on top of Roche's Tecentriq
15 Oct 2024 19:25 GMT
… in extensive-stage small cell lung cancer (ES-SCLC).
Zepzelca, used in … /m2 in combination with irinotecan, versus physician’s choice of …
-
Goals of Therapy and Considerations for Treatment Sequencing in Extensive Stage Small Cell Lung Cancer
11 Oct 2024 17:15 GMT
… of extensive stage small cell lung cancer (ES-SCLC) that progress within … as tarlatamab, lurbinectedin, topotecan, and irinotecan should be considered, alongside the …
About
© 1995-2025